Manja Hermina Boerman

Consort Medical Ltd. is a holding company, which engages in pharmaceutical industry related activities. It focuses on the design, development, manufacture, and sale of medical drug and delivery devices. The company was founded on March 22, 1946 and is headquartered in Kings Lynn, the United Kingdom.

Pharmaron Manufacturing Services (UK) Ltd. operates as pharmaceutical contract development and manufacturing company. It offers process research and development, analytical, clinical manufacturing and trial supply, and regulatory and support chain services. The company was founded in 2004 and is headquartered in Hemel Hempstead, the United Kingdom.

Part of Pharmaron Beijing Co., Ltd., Aesica Queenborough Ltd. is a British pharmaceutical company founded in 2007. The company is based in Hemel Hempstead, UK. The company researches, develops, and manufactures pharmaceutical products.

Part of Pharmaron Beijing Co., Ltd., Aesica Pharmaceuticals GmbH is a German company that manufactures pharmaceutical ingredients. The company is based in Monheim, Germany. The CEOs of the company are Jonathan Martin Glenn, Manja Hermina Elisabeth Maria Boerman, Werner Schick.

Patheon Biologics LLC manufactures, supplies clinical and commercial bulk biologics to the biopharmaceutical industry. The company was founded in 2010 and is headquartered in Jefferson City, MO.

Part of DSM BV, DSM Biologics BV is a Dutch company that develops and produces nutrition, pharmacy, and material science products. The company is based in Groningen, the Netherlands.

Kiadis Pharma BV operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. Its products include: ATIR101 and ATIR201. The firm’s products are based on hematopoietic blood-forming stem cell transplants from donors. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands.

Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands.